Loading...

Pharmaceutical Excipients: Properties, Functionality, and Applications in Research and Industry

ISBN: 978-1-118-14564-7

October 2016

352 pages

Description

Considered essential to pharmaceutical drug product development, pharmaceutical excipients are materials, other than the active moiety, intentionally included in a drug product for the purpose of ensuring it is acceptable to regulatory authorities and patients in terms of manufacturability and performance.  Pharmaceutical excipients are a very diverse group of materials, of either natural or synthetic origins, and can range from very simple molecules to complex high molecular weight polymers. Having a good foundation in the field of excipients, how they are developed, regulated and understanding their properties and effects is crucial for dosage formulation.

Pharmaceutical Excipients: Properties, Functionality, and Applications in Research and Industry provides a broad overview of excipients, their functionalities in pharmaceutical dosage forms, and how their selection can influence pharmaceutical products manufacture. Eight detailed chapters encompass the development, characterization, applications and case studies, harmonization, and research in the field of excipients.

Including up-to-date advancements of excipients used for pharmaceutical development; this valuable resource for scientists, researchers, regulatory personnel, and chemical engineers encompasses the overview, applications, and most current research. Pharmaceutical Excipients offers key benefits that include:

  • Coverage of the sources, characterization, and harmonization of excipients: essential information for optimal excipients selection in pharmaceutical development
  • Description of the physico-chemical properties and biological effects of excipients
  • Discussion of chemical classes, safety and toxicity, and formulation
  • Explanation of recent efforts in the standardization and harmonization of excipients
  • Presentation of the development and regulatory considerations for new excipients
About the Author
Otilia M.Y. Koo, PhD, is currently Integrated Development Team Leader at Bristol-Myers Squibb Company. Her research interests and publications are in excipients characterization and the role of excipients in formulation development and processes. She serves on the 2015 - 2020 United States Pharmacopeia Expert Committee for Excipient Monographs and was lead guest editor of themed issues of the AAPS Journal and AAPS Pharm SciTech. She received her PhD in Pharmaceutics from the University of Illinois at Chicago and Masters/Bachelors from the National University of Singapore. She also is an adjunct assistant professor at University of Illinois at Chicago.